CONOLIDINE PROLEVIATE FOR JOINT PAIN TREATMENT FUNDAMENTALS EXPLAINED

Conolidine’s analgesic results stem from its conversation with non-opioid pain pathways. Unlike opioids, which bind to µ-opioid receptors while in the central nervous method, conolidine modulates alternate molecular targets. A Science Innovations analyze discovered that conolidine interacts Along with the atypical chemokine receptor ACKR3/CXCR7,